TY - JOUR
T1 - Impact of the COVID-19 pandemic on routine vaccine landscape
T2 - A global perspective
AU - Basu, Soumya
AU - Ashok, Gayathri
AU - Debroy, Reetika
AU - Ramaiah, Sudha
AU - Livingstone, Paul
AU - Anbarasu, Anand
N1 - Publisher Copyright:
© 2023 The Author(s). Published with license by Taylor & Francis Group, LLC.
PY - 2023/4/20
Y1 - 2023/4/20
N2 - The coronavirus disease (COVID-19) threat is subsiding through extensive vaccination worldwide. However, the pandemic imposed major disruptions in global immunization programs and has aggravated the risks of vaccine-preventable disease (VPD) outbreaks. Particularly, lower-middle-income regions with minimal vaccine coverage and circulating vaccine-derived viral strains, such as polio, suffered additional burden of accumulated zero-dose children, further making them vulnerable to VPDs. However, there is no compilation of routine immunization disruptions and recovery prospects. There is a noticeable change in the routine vaccination coverage across different phases of the pandemic in six distinct global regions. We have summarized the impact of COVID-19 on routine global vaccination programs and also identified the prospects of routine immunization to combat COVID-like outbreaks.
AB - The coronavirus disease (COVID-19) threat is subsiding through extensive vaccination worldwide. However, the pandemic imposed major disruptions in global immunization programs and has aggravated the risks of vaccine-preventable disease (VPD) outbreaks. Particularly, lower-middle-income regions with minimal vaccine coverage and circulating vaccine-derived viral strains, such as polio, suffered additional burden of accumulated zero-dose children, further making them vulnerable to VPDs. However, there is no compilation of routine immunization disruptions and recovery prospects. There is a noticeable change in the routine vaccination coverage across different phases of the pandemic in six distinct global regions. We have summarized the impact of COVID-19 on routine global vaccination programs and also identified the prospects of routine immunization to combat COVID-like outbreaks.
KW - COVID-19
KW - disruption
KW - routine immunization
KW - vaccines
UR - http://www.scopus.com/inward/record.url?scp=85153510226&partnerID=8YFLogxK
U2 - 10.1080/21645515.2023.2199656
DO - 10.1080/21645515.2023.2199656
M3 - Review article
C2 - 37078597
AN - SCOPUS:85153510226
SN - 2164-5515
VL - 19
JO - Human Vaccines and Immunotherapeutics
JF - Human Vaccines and Immunotherapeutics
IS - 1
M1 - 2199656
ER -